Rates of colon cancer in Canada aren’t standard across the board. They’re dropping in populations over 50 years old, and rising in younger demographics. Dr. Jeff Axler, Medcan’s director of gastroenterology and endoscopy, has scoped over 40,000 colons throughout his career. Here, he chats with CMO Dr. Peter Nord about why Medcan’s colon cancer screening guidelines stand out from other recommendations in Canada, how you can learn about your unique risk, and why the preparation for your colonoscopy isn’t nearly as bad as you thought.

Women’s wellness is under-discussed, under-researched and under-considered by the Canadian healthcare system—and Breast Cancer Awareness month is a great time to explore two key aspects of women’s health: Breast cancer and menopause. What are the implications of 422,000 missed mammograms in Ontario during the pandemic? Why do we know so little about menopause? What do you need to know about screenings and your health, and where can you access important resources? Bronwen Evans, Medcan’s chief growth officer, explores these topics and more with Dr. Vivien Brown, MD, (pictured above) accomplished speaker and author who specializes in women’s health and healthy aging.

“Liquid biopsy” is a form of cancer screening that detects biomarkers in the blood with a simple draw. Research indicates that it could help to detect disease months or even years before other, more expensive and more invasive forms of screening, helping to save lives. So how exactly does it work? Is it better at detecting some cancers compared to others? And how can it help oncologists treat already diagnosed cases? Medcan’s director of clinical innovation, Allison Hazell, investigates with the help of Dr. Lewis Roberts (pictured above), director of the Mayo Clinic’s Hepatobiliary Cancer Lab.